• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 的抗肿瘤基因治疗研究进展。

Advancements in -Based Anti-Tumor Gene Therapy Research.

机构信息

Institute of Modern Fermentation Engineering and Future Foods, School of Light Industry and Food Engineering, Guangxi University, No. 100, Daxuedong Road, Nanning 530004, China.

School of Pharmaceutical Sciences and Institute of Materia Medica, Xinjiang University, Urumqi 830017, China.

出版信息

Molecules. 2024 Nov 11;29(22):5315. doi: 10.3390/molecules29225315.

DOI:10.3390/molecules29225315
PMID:39598704
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11596491/
Abstract

The gene is one of the genes most closely associated with human tumors and has become a popular target for tumor drug design. Currently, -based gene therapy techniques have been developed, but these therapies face challenges such as immaturity, high safety hazards, limited efficacy, and low patient acceptance. However, researchers are no less enthusiastic about the treatment because of its theoretical potential to treat cancer. In this paper, the advances in -based gene therapy and related nucleic acid delivery technologies were reviewed and prospected in order to support further development in this field.

摘要

该基因是与人类肿瘤关系最密切的基因之一,已成为肿瘤药物设计的热门靶点。目前,已经开发了基于的基因治疗技术,但这些疗法面临不成熟、安全性高、疗效有限和患者接受度低等挑战。然而,由于其治疗癌症的理论潜力,研究人员对这种治疗方法的热情并未减少。本文综述了基于的基因治疗及相关核酸传递技术的研究进展,并对其进行了展望,以期为该领域的进一步发展提供支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0640/11596491/9deddf8be831/molecules-29-05315-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0640/11596491/dfba41bc9060/molecules-29-05315-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0640/11596491/d48165bf5c77/molecules-29-05315-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0640/11596491/909dd15f0d03/molecules-29-05315-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0640/11596491/9deddf8be831/molecules-29-05315-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0640/11596491/dfba41bc9060/molecules-29-05315-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0640/11596491/d48165bf5c77/molecules-29-05315-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0640/11596491/909dd15f0d03/molecules-29-05315-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0640/11596491/9deddf8be831/molecules-29-05315-g004.jpg

相似文献

1
Advancements in -Based Anti-Tumor Gene Therapy Research.基于 的抗肿瘤基因治疗研究进展。
Molecules. 2024 Nov 11;29(22):5315. doi: 10.3390/molecules29225315.
2
Non-viral Delivery Systems for the Application in p53 Cancer Gene Therapy.用于p53癌症基因治疗的非病毒递送系统
Curr Med Chem. 2015;22(35):4118-36. doi: 10.2174/0929867322666151001121601.
3
p53 Replacement Therapy for Cancer.癌症的p53替代疗法。
Recent Results Cancer Res. 2016;209:1-15. doi: 10.1007/978-3-319-42934-2_1.
4
Restoring the p53 'Guardian' Phenotype in p53-Deficient Tumor Cells with CRISPR/Cas9.利用 CRISPR/Cas9 技术恢复 p53 缺陷型肿瘤细胞中的 p53“守护者”表型。
Trends Biotechnol. 2018 Jul;36(7):653-660. doi: 10.1016/j.tibtech.2018.01.014. Epub 2018 Feb 22.
5
Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv.使用抗转铁蛋白受体单链抗体片段靶向的免疫脂质体复合物对癌症进行全身性p53基因治疗。
Mol Med. 2001 Oct;7(10):723-34.
6
A dual-targeting drug co-delivery system for tumor chemo- and gene combined therapy.一种用于肿瘤化疗和基因联合治疗的双重靶向药物共输送系统。
Mater Sci Eng C Mater Biol Appl. 2016 Jul 1;64:208-218. doi: 10.1016/j.msec.2016.03.083. Epub 2016 Apr 5.
7
p53 and PTEN/MMAC1/TEP1 gene therapy of human prostate PC-3 carcinoma xenograft, using transferrin-facilitated lipofection gene delivery strategy.采用转铁蛋白促进的脂质体转染基因递送策略,对人前列腺PC-3癌异种移植瘤进行p53和PTEN/MMAC1/TEP1基因治疗。
Hum Gene Ther. 2002 Apr 10;13(6):761-73. doi: 10.1089/104303402317322311.
8
New p53-based anti-cancer therapeutic strategies.基于p53的新型抗癌治疗策略。
Med Oncol. 1998 Dec;15(4):222-8. doi: 10.1007/BF02787204.
9
Recent advances in p53 research and cancer treatment.p53研究与癌症治疗的最新进展。
J Biomed Biotechnol. 2011;2011:978312. doi: 10.1155/2011/978312. Epub 2011 Jun 16.
10
Prospects for p53-based cancer therapy.基于p53的癌症治疗前景。
Acta Biochim Pol. 2005;52(2):321-8. Epub 2005 Jun 25.

引用本文的文献

1
The Multifaceted Role of p53 in Cancer Molecular Biology: Insights for Precision Diagnosis and Therapeutic Breakthroughs.p53在癌症分子生物学中的多面角色:精准诊断与治疗突破的见解
Biomolecules. 2025 Jul 27;15(8):1088. doi: 10.3390/biom15081088.
2
Molecular Mechanisms in the Carcinogenesis of Oral Squamous Cell Carcinoma: A Literature Review.口腔鳞状细胞癌发生的分子机制:文献综述
Biomolecules. 2025 Apr 25;15(5):621. doi: 10.3390/biom15050621.
3
Oncolytic Viruses in Ovarian Cancer: Where Do We Stand? A Narrative Review.卵巢癌中的溶瘤病毒:我们目前的进展如何?一篇叙述性综述。

本文引用的文献

1
Selective targeting of chemically modified miR-34a to prostate cancer using a small molecule ligand and an endosomal escape agent.使用小分子配体和内体逃逸剂将化学修饰的miR-34a选择性靶向前列腺癌。
Mol Ther Nucleic Acids. 2024 Apr 23;35(2):102193. doi: 10.1016/j.omtn.2024.102193. eCollection 2024 Jun 11.
2
Branched chemically modified poly(A) tails enhance the translation capacity of mRNA.分支化学修饰的聚腺苷酸尾增强了信使核糖核酸的翻译能力。
Nat Biotechnol. 2025 Feb;43(2):194-203. doi: 10.1038/s41587-024-02174-7. Epub 2024 Mar 22.
3
Microneedle-assisted dual delivery of PUMA gene and celastrol for synergistic therapy of rheumatoid arthritis through restoring synovial homeostasis.
Pathogens. 2025 Feb 3;14(2):140. doi: 10.3390/pathogens14020140.
4
Unraveling the Guardian: p53's Multifaceted Role in the DNA Damage Response and Tumor Treatment Strategies.解读守护者:p53在DNA损伤应答及肿瘤治疗策略中的多面角色
Int J Mol Sci. 2024 Dec 1;25(23):12928. doi: 10.3390/ijms252312928.
通过恢复滑膜稳态,采用微针辅助双递送PUMA基因和雷公藤红素协同治疗类风湿性关节炎
Bioact Mater. 2024 Mar 1;36:83-95. doi: 10.1016/j.bioactmat.2024.02.030. eCollection 2024 Jun.
4
CRISPR-Cas9 In Vivo Gene Editing of for Hereditary Angioedema.CRISPR-Cas9 体内基因编辑治疗遗传性血管性水肿。
N Engl J Med. 2024 Feb 1;390(5):432-441. doi: 10.1056/NEJMoa2309149.
5
Tumor microenvironment responsive nano-platform for overcoming sorafenib resistance of hepatocellular carcinoma.用于克服肝细胞癌索拉非尼耐药性的肿瘤微环境响应性纳米平台
Mater Today Bio. 2023 Dec 15;24:100902. doi: 10.1016/j.mtbio.2023.100902. eCollection 2024 Feb.
6
VERVE-101: a promising CRISPR-based gene editing therapy that reduces LDL-C and PCSK9 levels in HeFH patients.VERVE-101:一种有前景的基于CRISPR的基因编辑疗法,可降低杂合子家族性高胆固醇血症(HeFH)患者的低密度脂蛋白胆固醇(LDL-C)和前蛋白转化酶枯草溶菌素9(PCSK9)水平。
Eur Heart J Cardiovasc Pharmacother. 2024 Feb 23;10(2):89-90. doi: 10.1093/ehjcvp/pvad103.
7
Immunologic Signatures of Peripheral Blood T Cells Reveal the Outcome of p53MVA Vaccine and Pembrolizumab Treatment in Patients with Advanced Ovarian Cancer.外周血 T 细胞的免疫特征揭示了 p53MVA 疫苗和帕博利珠单抗治疗晚期卵巢癌患者的结果。
Cancer Res Commun. 2023 Dec 20;3(12):2585-2595. doi: 10.1158/2767-9764.CRC-23-0394.
8
Intraperitoneal Administration of p53-armed Oncolytic Adenovirus Inhibits Peritoneal Metastasis of Diffuse-type Gastric Cancer Cells.腹腔内给予 p53 武装溶瘤腺病毒抑制弥漫型胃癌细胞的腹膜转移。
Anticancer Res. 2023 Nov;43(11):4809-4821. doi: 10.21873/anticanres.16678.
9
Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells.临床 CRISPR-Cas9 基因编辑 T 细胞中染色体丢失的减轻。
Cell. 2023 Oct 12;186(21):4567-4582.e20. doi: 10.1016/j.cell.2023.08.041. Epub 2023 Oct 3.
10
Development of an genotoxicity assay to detect retroviral vector-induced lymphoid insertional mutants.开发一种用于检测逆转录病毒载体诱导的淋巴样插入突变体的遗传毒性检测方法。
Mol Ther Methods Clin Dev. 2023 Aug 22;30:515-533. doi: 10.1016/j.omtm.2023.08.017. eCollection 2023 Sep 14.